Amgen Common
(AMGN)
|
5.1 |
$134M |
|
556k |
241.75 |
Gilead Sciences Common
(GILD)
|
4.9 |
$129M |
|
1.6M |
82.97 |
Regeneron Pharmaceuticals Common
(REGN)
|
4.5 |
$118M |
|
143k |
821.67 |
Johnson & Johnson Common
(JNJ)
|
4.3 |
$112M |
|
722k |
155.00 |
Unitedhealth Group Common
(UNH)
|
4.2 |
$111M |
|
234k |
472.59 |
Vertex Pharmaceuticals Common
(VRTX)
|
4.0 |
$104M |
|
330k |
315.07 |
Eli Lilly and Company Common
(LLY)
|
3.8 |
$99M |
|
289k |
343.42 |
AbbVie Common
(ABBV)
|
3.1 |
$82M |
|
512k |
159.37 |
Illumina Common
(ILMN)
|
3.1 |
$81M |
|
348k |
232.55 |
Pfizer Common
(PFE)
|
2.8 |
$72M |
|
1.8M |
40.80 |
AstraZeneca Sponsored ADR
(AZN)
|
2.6 |
$69M |
|
993k |
69.41 |
Biogen Common
(BIIB)
|
2.6 |
$67M |
|
241k |
278.03 |
Abbott Laboratories Common
(ABT)
|
2.4 |
$63M |
|
624k |
101.26 |
Merck & Co Common
(MRK)
|
2.2 |
$59M |
|
552k |
106.39 |
Thermo Fisher Scientific Common
(TMO)
|
2.1 |
$54M |
|
94k |
576.37 |
Elevance Health Common
(ELV)
|
2.0 |
$53M |
|
114k |
459.81 |
Moderna Common
(MRNA)
|
1.9 |
$50M |
|
322k |
153.58 |
Cigna Group Common
(CI)
|
1.8 |
$47M |
|
183k |
255.53 |
Bristol-Myers Squibb Company Common
(BMY)
|
1.8 |
$46M |
|
664k |
69.31 |
Seagen Common
|
1.7 |
$46M |
|
225k |
202.47 |
Sarepta Therapeutics Common
(SRPT)
|
1.5 |
$39M |
|
286k |
137.83 |
argenx SE Sponsored ADR
(ARGX)
|
1.3 |
$33M |
|
88k |
372.58 |
IDEXX Laboratories Common
(IDXX)
|
1.1 |
$29M |
|
59k |
500.08 |
BioMarin Pharmaceutical Common
(BMRN)
|
1.1 |
$29M |
|
300k |
97.24 |
Intuitive Surgical Common
(ISRG)
|
1.1 |
$29M |
|
113k |
255.47 |
Alnylam Pharmaceuticals Common
(ALNY)
|
1.1 |
$29M |
|
143k |
200.32 |
Boston Scientific Corp. Common
(BSX)
|
1.1 |
$28M |
|
566k |
50.03 |
Medtronic Shares
(MDT)
|
1.1 |
$28M |
|
345k |
80.62 |
Danaher Corp. Common
(DHR)
|
1.0 |
$27M |
|
106k |
252.04 |
Dexcom Common
(DXCM)
|
1.0 |
$27M |
|
229k |
116.18 |
Charles River Laboratories International Common
(CRL)
|
0.9 |
$24M |
|
118k |
201.82 |
McKesson Corp. Common
(MCK)
|
0.9 |
$24M |
|
67k |
356.05 |
HCA Healthcare Common
(HCA)
|
0.9 |
$23M |
|
89k |
263.68 |
Zoetis Class A
(ZTS)
|
0.9 |
$23M |
|
137k |
166.44 |
Jazz Pharmaceuticals Shares
(JAZZ)
|
0.8 |
$22M |
|
148k |
146.33 |
Stryker Corp. Common
(SYK)
|
0.8 |
$20M |
|
72k |
285.47 |
Humana Common
(HUM)
|
0.7 |
$18M |
|
37k |
485.46 |
Novo Nordisk A/S Sponsored ADR
(NVO)
|
0.7 |
$18M |
|
111k |
159.14 |
Molina Healthcare Common
(MOH)
|
0.6 |
$17M |
|
62k |
267.49 |
ResMed Common
(RMD)
|
0.6 |
$16M |
|
73k |
218.99 |
Edwards Lifesciences Corp. Common
(EW)
|
0.5 |
$14M |
|
171k |
82.73 |
Exelixis Common
(EXEL)
|
0.5 |
$14M |
|
727k |
19.41 |
United Therapeutics Corp. Common
(UTHR)
|
0.5 |
$14M |
|
61k |
223.96 |
Acadia Healthcare Company Common
(ACHC)
|
0.5 |
$14M |
|
187k |
72.25 |
Ascendis Pharma A/S Sponsored ADR
(ASND)
|
0.5 |
$13M |
|
124k |
107.22 |
uniQure Shares
(QURE)
|
0.5 |
$13M |
|
652k |
20.14 |
Physicians Realty Trust Common
|
0.5 |
$13M |
|
874k |
14.93 |
BioNTech SE Sponsored ADS
(BNTX)
|
0.5 |
$13M |
|
104k |
124.57 |
IQVIA Holdings Common
(IQV)
|
0.5 |
$13M |
|
63k |
198.89 |
Novartis Sponsored ADR
(NVS)
|
0.5 |
$13M |
|
136k |
92.00 |
Neurocrine Biosciences Common
(NBIX)
|
0.4 |
$11M |
|
113k |
101.22 |
SPDR S&P Biotech ETF S&P Biotech ETF
(XBI)
|
0.4 |
$11M |
|
148k |
76.21 |
Guardant Health Common
(GH)
|
0.4 |
$11M |
|
472k |
23.44 |
Oculis Holding Common
|
0.4 |
$11M |
|
1.7M |
6.53 |
Rallybio Corporation Common
(RLYB)
|
0.4 |
$9.9M |
|
1.7M |
5.71 |
Avantor Common
(AVTR)
|
0.4 |
$9.7M |
|
460k |
21.14 |
Karuna Therapeutics Common
|
0.4 |
$9.7M |
|
54k |
181.64 |
Travere Therapeutics Common
(TVTX)
|
0.4 |
$9.4M |
|
419k |
22.49 |
Intra-Cellular Therapies Common
(ITCI)
|
0.4 |
$9.3M |
|
172k |
54.15 |
Laboratory Corporation of America Holdings Common
|
0.3 |
$9.2M |
|
40k |
229.42 |
Apellis Pharmaceuticals Common
(APLS)
|
0.3 |
$8.9M |
|
135k |
65.96 |
Alkermes Shares
(ALKS)
|
0.3 |
$8.7M |
|
310k |
28.19 |
Zimmer Biomet Holdings Common
(ZBH)
|
0.3 |
$8.7M |
|
67k |
129.20 |
Omega Healthcare Investors Common
(OHI)
|
0.3 |
$8.4M |
|
306k |
27.41 |
Cytokinetics Common
(CYTK)
|
0.3 |
$7.7M |
|
219k |
35.19 |
Denali Therapeutics Common
(DNLI)
|
0.3 |
$7.5M |
|
325k |
23.04 |
CVS Health Corp. Common
(CVS)
|
0.3 |
$7.0M |
|
94k |
74.31 |
Sanofi Sponsored ADR
(SNY)
|
0.3 |
$6.7M |
|
124k |
54.42 |
Lantheus Holdings Common
(LNTH)
|
0.2 |
$6.6M |
|
80k |
82.56 |
LTC Properties Common
(LTC)
|
0.2 |
$6.4M |
|
182k |
35.13 |
Agilent Technologies Common
(A)
|
0.2 |
$6.0M |
|
43k |
138.34 |
Steris Shares
(STE)
|
0.2 |
$5.9M |
|
31k |
191.28 |
Sabra Health Care REIT Common
(SBRA)
|
0.2 |
$5.9M |
|
511k |
11.50 |
VectivBio Holding Common
|
0.2 |
$5.9M |
|
683k |
8.60 |
Intellia Therapeutics Common
(NTLA)
|
0.2 |
$5.7M |
|
154k |
37.27 |
Veradigm Common
(MDRX)
|
0.2 |
$5.6M |
|
429k |
13.05 |
Prometheus Biosciences Common
|
0.2 |
$5.4M |
|
51k |
107.32 |
R1 RCM Common
(RCM)
|
0.2 |
$5.4M |
|
357k |
15.00 |
West Pharmaceutical Services Common
(WST)
|
0.2 |
$5.2M |
|
15k |
346.47 |
Smith & Nephew Sponsored ADR
(SNN)
|
0.2 |
$5.1M |
|
182k |
27.91 |
Amedisys Common
(AMED)
|
0.2 |
$5.1M |
|
69k |
73.55 |
Addus HomeCare Corp. Common
(ADUS)
|
0.2 |
$4.5M |
|
42k |
106.76 |
BeiGene Sponsored ADR
(BGNE)
|
0.2 |
$4.5M |
|
21k |
215.53 |
Cerevel Therapeutics Holdings Common
(CERE)
|
0.2 |
$4.3M |
|
177k |
24.39 |
BioCryst Pharmaceuticals Common
(BCRX)
|
0.2 |
$4.2M |
|
505k |
8.34 |
Teva Pharmaceutical Industries Sponsored ADR
(TEVA)
|
0.2 |
$4.1M |
|
460k |
8.85 |
Adaptive Biotechnologies Corp. Common
(ADPT)
|
0.1 |
$3.7M |
|
422k |
8.83 |
Cardiovascular Systems Common
|
0.1 |
$3.5M |
|
175k |
19.86 |
Kura Oncology Common
(KURA)
|
0.1 |
$3.5M |
|
283k |
12.23 |
Medical Properties Trust Common
(MPW)
|
0.1 |
$3.4M |
|
412k |
8.22 |
Healthcare Realty Trust Common
(HR)
|
0.1 |
$3.4M |
|
175k |
19.33 |
Healthpeak Properties Common
(DOC)
|
0.1 |
$3.3M |
|
150k |
21.97 |
Amerisourcebergen Corp. Common
(COR)
|
0.1 |
$3.3M |
|
20k |
160.11 |
Catalent Common
(CTLT)
|
0.1 |
$3.2M |
|
49k |
65.71 |
Ishares Biothechnology ETF Common
(IBB)
|
0.1 |
$3.2M |
|
25k |
129.16 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.1 |
$3.2M |
|
457k |
6.90 |
Ionis Pharmaceuticals Common
(IONS)
|
0.1 |
$3.1M |
|
88k |
35.74 |
Blueprint Medicines Corp. Common
(BPMC)
|
0.1 |
$3.0M |
|
68k |
44.99 |
Madrigal Pharmaceuticals Common
(MDGL)
|
0.1 |
$3.0M |
|
13k |
242.26 |
Caribou Biosciences Common
(CRBU)
|
0.1 |
$3.0M |
|
567k |
5.31 |
Xenon Pharmaceuticals Common
(XENE)
|
0.1 |
$3.0M |
|
84k |
35.79 |
Welltower Common
(WELL)
|
0.1 |
$3.0M |
|
42k |
71.69 |
Ventas Common
(VTR)
|
0.1 |
$2.9M |
|
67k |
43.35 |
Pyxis Oncology Common
(PYXS)
|
0.1 |
$2.8M |
|
708k |
4.01 |
LivaNova Common
(LIVN)
|
0.1 |
$2.8M |
|
64k |
43.58 |
Natera Common
(NTRA)
|
0.1 |
$2.7M |
|
49k |
55.52 |
Baxter International Common
(BAX)
|
0.1 |
$2.7M |
|
67k |
40.56 |
Ultragenyx Pharmaceutical Common
(RARE)
|
0.1 |
$2.7M |
|
67k |
40.10 |
Assertio Holdings Common
(ASRT)
|
0.1 |
$2.6M |
|
411k |
6.37 |
Ardelyx Common
(ARDX)
|
0.1 |
$2.6M |
|
539k |
4.79 |
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.1 |
$2.6M |
|
100k |
25.40 |
Bridgebio Pharma Common
(BBIO)
|
0.1 |
$2.5M |
|
151k |
16.58 |
CRISPR Therapeutics Namen AKT
(CRSP)
|
0.1 |
$2.5M |
|
55k |
45.23 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.1 |
$2.5M |
|
118k |
21.12 |
Mirati Therapeutics Common
|
0.1 |
$2.4M |
|
66k |
37.18 |
Align Technology Common
(ALGN)
|
0.1 |
$2.3M |
|
6.9k |
334.14 |
Galera Therapeutics Common
(GRTX)
|
0.1 |
$2.3M |
|
898k |
2.56 |
Option Care Health Common
(OPCH)
|
0.1 |
$2.1M |
|
65k |
31.77 |
Koninklijke Philips NY Reg Shares
(PHG)
|
0.1 |
$2.0M |
|
110k |
18.35 |
Icon Shares
(ICLR)
|
0.1 |
$2.0M |
|
9.3k |
213.59 |
Chinook Therapeutics Common
|
0.1 |
$1.9M |
|
84k |
23.15 |
Bicycle Therapeutics Sponsored ADS
(BCYC)
|
0.1 |
$1.9M |
|
89k |
21.27 |
Perrigo Company Shares
(PRGO)
|
0.1 |
$1.8M |
|
51k |
35.87 |
Immunovant Common
(IMVT)
|
0.1 |
$1.8M |
|
115k |
15.51 |
Medpace Holdings Common
(MEDP)
|
0.1 |
$1.8M |
|
9.4k |
188.05 |
Takeda Pharmaceutical Company Sponsored ADS
(TAK)
|
0.1 |
$1.7M |
|
105k |
16.48 |
Arcutis Biotherapeutics Common
(ARQT)
|
0.1 |
$1.6M |
|
149k |
11.00 |
Reata Pharmaceuticals, Inc. Class A Class A
|
0.1 |
$1.6M |
|
18k |
90.92 |
89bio Common
(ETNB)
|
0.1 |
$1.6M |
|
106k |
15.23 |
Global Medical REIT Common
(GMRE)
|
0.1 |
$1.6M |
|
175k |
9.11 |
GSK Sponsored ADR
(GSK)
|
0.1 |
$1.5M |
|
42k |
35.58 |
Edgewise Therapeutics Common
(EWTX)
|
0.0 |
$1.3M |
|
195k |
6.67 |
Merus Common
(MRUS)
|
0.0 |
$1.3M |
|
69k |
18.40 |
Crinetics Pharmaceuticals Common
(CRNX)
|
0.0 |
$1.3M |
|
79k |
16.06 |
Zai Lab Adr
(ZLAB)
|
0.0 |
$1.2M |
|
35k |
33.26 |
G1 Therapeutics Common
|
0.0 |
$1.1M |
|
424k |
2.68 |
Mereo BioPharma Group Ads
(MREO)
|
0.0 |
$1.1M |
|
1.6M |
0.71 |
Scholar Rock Holding Corp. Common
(SRRK)
|
0.0 |
$871k |
|
109k |
8.00 |
Intercept Pharmaceuticals Common
|
0.0 |
$699k |
|
52k |
13.43 |
Mersana Therapeutics Common
(MRSN)
|
0.0 |
$667k |
|
162k |
4.11 |
Theseus Pharmaceuticals Common
|
0.0 |
$666k |
|
75k |
8.88 |
iTeos Therapeutics Common
(ITOS)
|
0.0 |
$623k |
|
46k |
13.61 |
Arcus Biosciences Common
(RCUS)
|
0.0 |
$599k |
|
33k |
18.24 |
Tactile Systems Technology Common
(TCMD)
|
0.0 |
$565k |
|
34k |
16.42 |
I-Mab Sponsored ADS
(IMAB)
|
0.0 |
$563k |
|
163k |
3.46 |
Community Healthcare Trust Common
(CHCT)
|
0.0 |
$545k |
|
15k |
36.60 |
Universal Health Realty Income Trust Common
(UHT)
|
0.0 |
$542k |
|
11k |
48.11 |
National Health Investors Common
(NHI)
|
0.0 |
$518k |
|
10k |
51.58 |
Beam Therapeutics Common
(BEAM)
|
0.0 |
$484k |
|
16k |
30.62 |
Diversified Healthcare Trust Common
(DHC)
|
0.0 |
$483k |
|
358k |
1.35 |
Biohaven Common
(BHVN)
|
0.0 |
$479k |
|
35k |
13.66 |
Sutro Biopharma Common
(STRO)
|
0.0 |
$454k |
|
98k |
4.62 |
Novavax Common
(NVAX)
|
0.0 |
$442k |
|
64k |
6.93 |
Affimed Common
|
0.0 |
$437k |
|
586k |
0.75 |
Community Health Systems Common
(CYH)
|
0.0 |
$433k |
|
88k |
4.90 |
TScan Therapeutics Common
(TCRX)
|
0.0 |
$420k |
|
200k |
2.10 |
MorphoSys Sponsored ADS
(MOR)
|
0.0 |
$323k |
|
82k |
3.95 |
Altimmune Common
(ALT)
|
0.0 |
$317k |
|
75k |
4.22 |
ALX Oncology Holdings Common
(ALXO)
|
0.0 |
$299k |
|
66k |
4.52 |
Repare Therapeutics Common
(RPTX)
|
0.0 |
$287k |
|
29k |
9.84 |
Codexis Common
(CDXS)
|
0.0 |
$286k |
|
69k |
4.14 |
Mallinckrodt Shares
|
0.0 |
$256k |
|
35k |
7.29 |
Black Diamond Therapeutics Common
(BDTX)
|
0.0 |
$250k |
|
132k |
1.89 |
Adicet Bio Common
(ACET)
|
0.0 |
$232k |
|
40k |
5.76 |
Harpoon Therapeutics Common
|
0.0 |
$193k |
|
260k |
0.74 |
Vaxcyte Common
(PCVX)
|
0.0 |
$187k |
|
5.0k |
37.48 |
Precision BioSciences Common
|
0.0 |
$169k |
|
225k |
0.75 |
Fulcrum Therapeutics Common
(FULC)
|
0.0 |
$167k |
|
59k |
2.85 |
Fusion Pharmaceuticals Common
|
0.0 |
$164k |
|
43k |
3.77 |
Nkarta Common
(NKTX)
|
0.0 |
$103k |
|
29k |
3.55 |
Spectrum Pharmaceuticals Common
|
0.0 |
$86k |
|
115k |
0.75 |
ARCA biopharma Common
(ABIO)
|
0.0 |
$65k |
|
33k |
1.99 |
Praxis Precision Medicines Common
|
0.0 |
$61k |
|
75k |
0.81 |
Corbus Pharmaceuticals Holdings Common
(CRBP)
|
0.0 |
$37k |
|
5.1k |
7.27 |
VYNE Therapeutics Common
(VYNE)
|
0.0 |
$23k |
|
7.5k |
3.08 |
NexGel Common
(NXGL)
|
0.0 |
$5.5k |
|
4.2k |
1.30 |
Bellicum Pharmaceuticals Common
|
0.0 |
$2.0k |
|
6.0k |
0.33 |